Evidence map›Paper›PMID 18929049›Full record

ReviewFertility and sterility2008

Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing.

D Andrew Crain, Sarah J Janssen, Thea M Edwards, Jerrold Heindel, Shuk-mei Ho, Patricia Hunt, Taisen Iguchi, Anders Juul, John A McLachlan, Jackie Schwartz and 8 more

Abstract readReview
In one paragraph

Review in Fertility and sterility, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 149 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
149citing papers in PubMed, 2 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

149 citing papers in PubMed, 2 syntheses or guidelines pooled it, 452 citations in OpenAlex.

  1. Health impacts of micro- and nanoplastics in humans: systematic review of in vivo evidence.Environmental health : a global access science source · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Endometriosis and autoimmunity.Autoimmunity reviews · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

89 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 14 institutions in 3 countries.

D Andrew CrainMaryville College, Maryville, Tennessee, USA.
Sarah J Janssen
Thea M Edwards
Jerrold Heindel
Shuk-mei Ho
Patricia Hunt
Taisen Iguchi
Anders Juul
John A McLachlan
Jackie Schwartz
Niels Skakkebaek
Ana M Soto
Shanna Swan
Cheryl Walker
Teresa K Woodruff
Tracey J Woodruff
Linda C Giudice
Louis J Guillette
University of California, San Francisco · USRigshospitalet · DKUniversity of Florida · USMaryville College · USNational Institute of Environmental Health Sciences · USNational Institutes of Natural Sciences · JPNatural Resources Defense Council · USNorthwestern University · USThe University of Texas MD Anderson Cancer Center · USTufts University · USUniversity of Cincinnati Medical Center · USUniversity of Rochester · USWashington State University · USXavier University of Louisiana · US

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI YADAV, JAGJIT S · 1992 to 2022
$35.4M
TRANSCRIPTION FACTOR INTERACTIONS IN REPRODUCTIVE HORMONE GENE EXPRESSIONU54HD041857 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MAYO, KELLY E · 2003 to 2012
$12.2M
U54: The Oncofertility Consortium: Fertility Preservation for Woman (1 of 10)UL1DE019587 · NIDCR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOODRUFF, TERESA K · 2008 to 2011
$3.7M
Project 3: Medically-based Protection of the Ovarian Reserve Against Anti-CancerU54HD076188 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOODRUFF, TERESA K · 2013 to 2013
$1.6M
The Oncofertility Consortium: Fertility Preservation for WomanUL1RR024926 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOODRUFF, TERESA K · 2007 to 2007
$692k
NCRR NIH HHS UL1 RR024926NICHD NIH HHS U54 HD041857NICHD NIH HHS U54 HD076188NIDCR NIH HHS UL1 DE019587NIEHS NIH HHS P30 ES006096
6 · The paper itself

Abstract

objectiveTo evaluate the possible role of endocrine-disrupting compounds (EDCs) on female reproductive disorders emphasizing developmental plasticity and the complexity of endocrine-dependent ontogeny of reproductive organs. Declining conception rates and the high incidence of female reproductive disruptions warrant evaluation of the impact of EDCs on female reproductive health.

designPublications related to the contribution of EDCs to disorders of the ovary (aneuploidy, polycystic ovary syndrome, and altered cyclicity), uterus (endometriosis, uterine fibroids, fetal growth restriction, and pregnancy loss), breast (breast cancer, reduced duration of lactation), and pubertal timing were identified, reviewed, and summarized at a workshop. CONCLUSION(S): The data reviewed illustrate that EDCs contribute to numerous human female reproductive disorders and emphasize the sensitivity of early life-stage exposures. Many research gaps are identified that limit full understanding of the contribution of EDCs to female reproductive problems. Moreover, there is an urgent need to reduce the incidence of these reproductive disorders, which can be addressed by correlative studies on early life exposure and adult reproductive dysfunction together with tools to assess the specific exposures and methods to block their effects. This review of the EDC literature as it relates to female health provides an important platform on which women's health can be improved.

Indexed as

Endocrine DisruptorsFemaleGenital Diseases, FemaleHumansPregnancyPregnancy OutcomeReproductionEndocrine Disruptors

Identifiers

PMID18929049
PMCPMC4086418
OpenAlexW2154968546

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.